medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2024, Number 4

<< Back Next >>

Rev ADM 2024; 81 (4)

Oral cancer: etiology, precancerous lesions and treatment.

Abril-Cordero LM, Lalangui-Matamoros JJ, Solís-Valencia EG, Solano-Maldonado DA, Quito-Zhinín AE, Moreno-Gálvez MD

Language: Spanish
References: 24
Page: 201-205
PDF size: 174.26 Kb.


ABSTRACT

Introduction: oral cancer is one of the most common malignant neoplasms in the world, despite the current diagnostic tools, there is a high degree of morbidity and mortality due to late diagnosis and lack of awareness of the population on the consumption of tobacco, alcohol, among other substances. Objective: the objective of this review is to provide present information of the precancerous lesions, etiology, diagnosis and treatment of oral cancer. Material and methods: a bibliographic search was carried out in five digital databases on peer-reviewed articles from 2015 to the present. Conclusion: oral cancer is a frequent pathology that can cause serious consequences and sequelae in people who suffer it, an extensive knowledge of premalignant lesions among with an early diagnosis by the professional and a greater awareness of risk factors, play a fundamental role to prevent the establishment and/or progression of this pathology.


REFERENCES

  1. D'souza S, Addepalli V. Preventive measures in oral cancer: an overview. Biomed Pharmacother. 2018; 107: 72-80.

  2. Ghantous Y, Elnaaj A. Global incidence and risk factors of oral cancer. Harefuah. 2017; 156 (10): 645-649.

  3. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015; 8 (9): 11884-1194.

  4. Manoharan S, Karthikeyan S, Essa MM, Manimaran A, Selvasundram R. An overview of oral carcinogenesis. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2016; 6 (2): 51-62.

  5. Shrestha AD, Vedsted P, Kallestrup P, Neupane D. Prevalence and incidence of oral cancer in low- and middle-income countries: A scoping review. Eur J Cancer Care (Engl). 2020; 29 (2): e13207.

  6. Alves CGB, Treister NS, Ribeiro ACP, Brandao TB, Tonaki JO, Lopes MA et al. Strategies for communicating oral and oropharyngeal cancer diagnosis: why talk about it? Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 129 (4): 347-356.

  7. Ramos-Garcia P, Roca-Rodriguez MDM, Aguilar-Diosdado M, Gonzalez-Moles MA. Diabetes mellitus and oral cancer/oral potentially malignant disorders: a systematic review and meta-analysis. Oral Dis. 2021; 27 (3): 404-421.

  8. Valdez JA, Brennan MT. Impact of oral cancer on quality of life. Dent Clin North Am. 2018; 62 (1): 143-154.

  9. Lafuente IMI, Maritxalar MX, García de la Fuente AM, Quindós AG, Aguirre UJM. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: a systematic review. J Periodontal Res. 2020; 55 (1): 13-22.

  10. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68 (6): 394-424.

  11. García-Martín JM, Varela-Centelles P, González M, Seoane-Romero JM, Seoane J, García-Pola MJ. Epidemiology of oral cancer. Oral Cancer Detection: Springer; 2019. p. 81-93.

  12. Villa A, Akintoye SO. Dental management of patients who have undergone oral cancer therapy. Dent Clin North Am. 2018; 62 (1): 131-142.

  13. Sarode GS, Sarode SC, Maniyar N, Anand R, Patil S. Oral cancer databases: a comprehensive review. J Oral Pathol Med. 2018; 47 (6): 547-556.

  14. Chaturvedi P, Singh A, Chien CY, Warnakulasuriya S. Tobacco related oral cancer. BMJ. 2019; 365: l2142.

  15. Tomar SL, Hecht SS, Jaspers I, Gregory RL, Stepanov I. Oral health effects of combusted and smokeless tobacco products. Adv Dent Res. 2019; 30 (1): 4-10.

  16. Pemberton M. Oral cancer and tobacco: developments in harm reduction. Br Dent J. 2018; 225 (9): 822.

  17. Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016; 12 (2): 458-463.

  18. Awadallah M, Idle M, Patel K, Kademani D. Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125 (6): 628-636.

  19. Gileva OS, Libik TV, Danilov KV, editors. Oral precancerous lesions: problems of early detection and oral cancer prevention. AIP Conference Proceedings; 2016: AIP Publishing LLC.

  20. Epstein JB, Miaskowski C. Oral Pain in the Cancer Patient. J Natl Cancer Inst Monogr. 2019; 2019 (53): lgz003.

  21. Ribeiro IP, Barroso L, Marques F, Melo JB, Carreira IM. Early detection and personalized treatment in oral cancer: the impact of omics approaches. Mol Cytogenet. 2016; 9: 85.

  22. Wong T, Wiesenfeld D. Oral cancer. Aust Dent J. 2018; 63 Suppl 1: S91-S99.

  23. D'Cruz AK, Vaish R, Dhar H. Oral cancers: current status. Oral Oncol. 2018; 87: 64-69.

  24. D'Silva NJ, Gutkind JS. Oral cancer: integration of studies for diagnostic and therapeutic precision. Adv Dent Res. 2019; 30 (2): 45-49.




2020     |     www.medigraphic.com